Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Candida species cause cutaneous and systemic infections with a high mortality rate, especially in immunocompromised patients. The emergence of resistance to the most common antifungal drugs, also due to biofilm formation, requires the development of alternative antifungal agents. The antimicrobial peptide VLL-28, isolated from an archaeal transcription factor, shows comparable antifungal activity against 10 clinical isolates of Candida spp. Using a fluoresceinated derivative of this peptide, we found that VLL-28 binds to the surface of planktonic cells. This observation suggested that it could exert its antifungal activity by damaging the cell wall. In addition, analyses performed on biofilms via confocal microscopy revealed that VLL-28 is differentially active on all the strains tested, with C. albicans and C. parapsilosis being the most sensitive ones. Notably, VLL-28 is the first example of an archaeal antimicrobial peptide that is active towards Candida spp. Thus, this points to archaeal microorganisms as a possible reservoir of novel antifungal agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
STEPANOVIĆ, S., VUKOVIĆ, D., HOLA, V., BONAVENTURA, G. D., DJUKIĆ, S., ĆIRKOVIĆ, I., & RUZICKA, F. (2007) · APMIS · doi:10.1111/j.1600-0463.2007.apm_630.x · Cited by 2,494
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Virulence factors of Candida albicans
Calderone, R. A., & Fonzi, W. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02094-7 · Cited by 1,331
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Guidelines for the prevention of intravascular catheter-related infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.01.003 · Cited by 1,066
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Guidelines for the Prevention of Intravascular Catheter–Related Infections
O’Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., et al. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502007 · Cited by 847
Lopez, D., Vlamakis, H., & Kolter, R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000398 · Cited by 797
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 764
Biofilm-specific antibiotic tolerance and resistance
Olsen, I. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2323-z · Cited by 737
Ramage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678
The superficial life of microbes
Kolter, R., & Greenberg, E. P. (2006) · Nature · doi:10.1038/441300a · Cited by 555
Al-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Nosocomial Candidemia: Risk Factors and Attributable Mortality
Wenzel, R. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1531 · Cited by 502
Host defense peptides: front-line immunomodulators
Mansour, S. C., Pena, O. M., & Hancock, R. E. W. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.07.004 · Cited by 488
Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-06 · Cited by 407
Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396
Echinocandin Antifungal Drugs in Fungal Infections: A Comparison
Chen, S. C.-A., Slavin, M. A., & Sorrell, T. C. (2011) · Drugs · doi:10.2165/11585270-000000000-00000 · Cited by 371
Tumbarello, M., Posteraro, B., Trecarichi, E. M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00131-07 · Cited by 343
Dadar, M., Tiwari, R., Karthik, K., Chakraborty, S., Shahali, Y., & Dhama, K. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.02.028 · Cited by 332
Adherence and biofilm formation of non-Candida albicans Candida species
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.02.003 · Cited by 304
Antimicrobial Peptides: An Introduction
Haney, E. F., Mansour, S. C., & Hancock, R. E. W. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6737-7_1 · Cited by 296
Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
Chung, P. Y., & Khanum, R. (2017) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2016.12.005 · Cited by 296
Human β-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral Microorganisms
Joly, S., Maze, C., McCray, P. B., & Guthmiller, J. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1024-1029.2004 · Cited by 291
Onyewu, C., Blankenship, J. R., Del Poeta, M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.956-964.2003 · Cited by 282
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Nagy, E., Dobiasova, S., Rinaldi, M., Barton, R., Veselov, A., & the Global Antifungal Surveillance Group (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01915-07 · Cited by 259
Use of Antimicrobial Peptides Against Microbial Biofilms: Advantages and Limits
Batoni, G., Maisetta, G., Lisa Brancatisano, F., Esin, S., & Campa, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794088399 · Cited by 252
Genetic Basis of Candida Biofilm Resistance Due to Drug‐Sequestering Matrix Glucan
Nett, J. E., Sanchez, H., Cain, M. T., & Andes, D. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/651200 · Cited by 250
de Groot, P. W. J., Kraneveld, E. A., Yin, Q. Y., Dekker, H. L., Groß, U., Crielaard, W., de Koster, C. G., Bader, O., Klis, F. M., & Weig, M. (2008) · Eukaryotic Cell · doi:10.1128/ec.00284-08 · Cited by 232
Mechanism of Fluconazole Resistance in Candida krusei
Orozco, A. S., Higginbotham, L. M., Hitchcock, C. A., Parkinson, T., Falconer, D., Ibrahim, A. S., Ghannoum, M. A., & Filler, S. G. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2645 · Cited by 218
The Mechanistic Targets of Antifungal Agents: An Overview
K. Mazu, T., A. Bricker, B., Flores-Rozas, H., & Y. Ablordeppey, S. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666160118112103 · Cited by 199
Montagna, M. T., Caggiano, G., Lovero, G., De Giglio, O., Coretti, C., Cuna, T., Iatta, R., Giglio, M., Dalfino, L., Bruno, F., et al. (2013) · Infection · doi:10.1007/s15010-013-0432-0 · Cited by 185
Tsai, P.-W., Yang, C.-Y., Chang, H.-T., & Lan, C.-Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017755 · Cited by 175
den HERTOG, A. L., van MARLE, J., van VEEN, H. A., van't HOF, W., BOLSCHER, J. G. M., VEERMAN, E. C. I., & NIEUW AMERONGEN, A. V. (2005) · Biochemical Journal · doi:10.1042/bj20042099 · Cited by 171
Khan, A., Khan, Azam, & Alam (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31219 · Cited by 167
Pane, K., Durante, L., Crescenzi, O., Cafaro, V., Pizzo, E., Varcamonti, M., Zanfardino, A., Izzo, V., Donato, A. D., & Notomista, E. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.02.012 · Cited by 143
Self-citationInterplay between Candida albicans and the Antimicrobial Peptide Armory
Swidergall, M., & Ernst, J. F. (2014) · Eukaryotic Cell · doi:10.1128/ec.00093-14 · Cited by 131
Biofilm Formation by and Antifungal Susceptibility of Candida Isolates from Urine
Jain, N., Kohli, R., Cook, E., Gialanella, P., Chang, T., & Fries, B. C. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02439-06 · Cited by 131
Wang, K., Dang, W., Xie, J., Zhu, R., Sun, M., Jia, F., Zhao, Y., An, X., Qiu, S., Li, X., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.07.008 · Cited by 121
Biofilms of Candida albicans and their associated resistance to antifungal agents.
Ramage, G., Wickes, B. L., & Lopez-Ribot, J. L. (2001) · PubMed · Cited by 112
Activity of Novel Synthetic Peptides against Candida albicans
Lum, K. Y., Tay, S. T., Le, C. F., Lee, V. S., Sabri, N. H., Velayuthan, R. D., Hassan, H. H., & Sekaran, S. D. (2015) · Scientific Reports · doi:10.1038/srep09657 · Cited by 110
Barra, F., Roscetto, E., Soriano, A. A., Vollaro, A., Postiglione, I., Pierantoni, G. M., Palumbo, G. A., & Catania, M. R. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160920417 · Cited by 110
Self-citationKhot, P. D., Suci, P. A., Miller, R. L., Nelson, R. D., & Tyler, B. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00997-06 · Cited by 104
Effects of histatin 5 and derived peptides on Candida albicans
Ruissen, A. L. A., Groenink, J., Helmerhorst, E. J., Walgreen-Weterings, E., Hof, W. V. ‘., Veerman, E. C. I., & Amerongen, A. V. N. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3560361 · Cited by 103
Pane, K., Sgambati, V., Zanfardino, A., Smaldone, G., Cafaro, V., Angrisano, T., Pedone, E. M., Gaetano, S. D., Capasso, D., Haney, E. F., et al. (2016) · FEBS Journal · doi:10.1111/febs.13725 · Cited by 84
Self-citationGaglione, R., Dell’Olmo, E., Bosso, A., Chino, M., Pane, K., Ascione, F., Itri, F., Caserta, S., Amoresano, A., Lombardi, A., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.009 · Cited by 84
Self-citationFungicidal Mechanisms of Cathelicidins LL-37 and CATH-2 Revealed by Live-Cell Imaging
Ordonez, S. R., Amarullah, I. H., Wubbolts, R. W., Veldhuizen, E. J. A., & Haagsman, H. P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01670-13 · Cited by 83
Comparative analysis of Candida biofilm quantitation assays
Taff, H. T., Nett, J. E., & Andes, D. R. (2012) · Medical Mycology · doi:10.3109/13693786.2011.580016 · Cited by 80
Biofilms in lab and nature: a molecular geneticist's voyage to microbial ecology.
Kolter, R. (2010) · Estudis Romànics (Institut d'Estudis Catalans) · doi:10.2436/20.1501.01.105 · Cited by 74
Vandecandelaere, I., & Coenye, T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-11038-7_9 · Cited by 67
Epidemiology and Prognostic Factors of Candidemia in Cancer Patients
Tang, H.-J., Liu, W.-L., Lin, H.-L., & Lai, C.-C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099103 · Cited by 66
Pelletier, R., Alarie, I., Lagacé, R., & Walsh, T. J. (2005) · Medical Mycology · doi:10.1080/13693780500220415 · Cited by 58
Fonseca, E., Silva, S., Rodrigues, C. F., Alves, C. T., Azeredo, J., & Henriques, M. (2014) · Biofouling · doi:10.1080/08927014.2014.886108 · Cited by 56
Panizo, M. M., Reviakina, V. A., Dolande, M., & Selgrad, S. (2008) · Medical Mycology · doi:10.1080/13693780802144339 · Cited by 55
Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins
Helmerhorst, E. J., Venuleo, C., Beri, A., & Oppenheim, F. G. (2005) · Yeast · doi:10.1002/yea.1241 · Cited by 53
Candida tropicalis biofilm's matrix—involvement on its resistance to amphotericin B
Fernandes, T., Silva, S. M., & Henriques, M. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.06.015 · Cited by 45
Pizzo, E., Cafaro, V., Donato, A. D., et al. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180327165012 · Cited by 45
Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm
Pulcrano, G., Panellis, D., Domenico, G., Rossano, F., & Catania, M. R. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2012.00792.x · Cited by 41
Self-citationMolecular biology of fuselloviruses and their satellites
Contursi, P., Fusco, S., Cannio, R., & She, Q. (2014) · Extremophiles · doi:10.1007/s00792-014-0634-0 · Cited by 36
Self-citationBosso, A., Pirone, L., Gaglione, R., Pane, K., Gatto, A. D., Zaccaro, L., Gaetano, S. D., Diana, D., Fattorusso, R., Pedone, E. M., et al. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.04.009 · Cited by 32
Self-citationFungal Biofilms in Human Disease
Williams, C., & Ramage, G. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09782-4_2 · Cited by 29
Neelabh, Singh, K., & Rani, J. (2016) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-016-9212-3 · Cited by 27
Prato, S., Vitale, R. M., Contursi, P., Lipps, G., Saviano, M., Rossi, M., & Bartolucci, S. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06585.x · Cited by 23
Self-citationPrażyńska, M. B., Bogiel, T., & Gospodarek-Komkowska, E. (2017) · Folia Microbiologica · doi:10.1007/s12223-017-0555-2 · Cited by 20
Singh, K. K., Shekhar, S., Yadav, Y., Xess, I., & Dey, S. (2017) · Journal of Peptide Science · doi:10.1002/psc.2973 · Cited by 14
Cited by
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Cytoskeletal Crosstalk in Cell Migration
Seetharaman, S., & Etienne-Manneville, S. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.06.004 · Cited by 470
Potential of microalgae as a sustainable feed ingredient for aquaculture
Nagappan, S., Das, P., AbdulQuadir, M., Thaher, M., Khan, S., Mahata, C., Al-Jabri, H., Vatland, A. K., & Kumar, G. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.09.003 · Cited by 364
Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation
Raheem, A., Liang, L., Zhang, G., & Cui, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616713 · Cited by 302
Pawlowski, J., Apothéloz‐Perret‐Gentil, L., & Altermatt, F. (2020) · Molecular Ecology · doi:10.1111/mec.15643 · Cited by 295
Metadata
- Authors
- Roscetto, E., Contursi, P., Vollaro, A., Fusco, S., Notomista, E., & Catania, M. R.
- Venue
- Scientific Reports
- Published
- 2018-12-04
- Volume
- 8
- Issue
- 1
- Pages
- 17570-17570
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2903234151
- Cited by
- 272
- References
- 74
- FWCI
- 37.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.